• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
Irish America

Irish America

        • Who We Are
          • About Us
          • Irish America Team
        • The Lists
          • Business 100
          • Hall of Fame
          • Health and Life Sciences 50
          • Wall Street 50
        • Highlights
          • History
          • In This Issue
          • Music
          • Politics
          • Sports
          • Travel
        • Columns
          • First Word
          • Hibernia
          • Quote Unquote
          • Slainte
          • Those we Lost
          • What are you like?
          • Wild Irish Women
          • Window on The Past
  • Home
  • Who We Are
    • About This Magazine
    • Irish America Team
  • In This Issue
  • Hall of Fame
  • The Lists
    • Business 100
    • Hall of Fame
    • Health and Life Sciences 50
    • Wall Street 50
  • Archives
    • Magazine
    • Highlights
  • Travel
  • Events

Dublin Researchers Lead Promising Alzheimer’s Study

By Adam Farley, Editorial Assistant
August / September 2013

August 1, 2013 by Leave a Comment

A healthy brain (left) and a brain in the advanced stages of Alzheimer’s, with visible cell loss.

An 18-month-long international study of a potential Alzheimer’s drug has begun, and Ireland is playing a big role. The project, coordinated by Brian Lawlor, Connolly Norman Professor of Old Age Psychiatry at Trinity College Dublin, is set to be one of the most intensive and significant studies in over a decade of Alzheimer’s treatment research.

Professor Lawlor has worked on dementia for almost his entire career and in 2011 applied for funding from the European Union to test whether the drug nilvadipine, currently used as a blood pressure medication, has any effects on the progression of Alzheimer’s Disease. Alzheimer’s Disease is the most common form of dementia and gradually advances over time, affecting memory, thinking, and behavior. Fifteen million people worldwide and one in six over the age of 80 suffer from Alzheimer’s.

After winning €6 million in funding, Lawlor created a consortium of Alzheimer’s experts from 16 organizations in the EU plus one Florida drug company to participate in a larger, 5-year study called NILVAD (Nilvadipine in Alzheimer’s Disease).

This 18-month study is the first major clinical trial of the larger research initiative and includes over 500 male and female participants (about 100 of whom come from Ireland), ages 50-90, who have been diagnosed with mild to moderate Alzheimers. Nilvadipine is already approved for use in humans for cardiovascular disease and showed promise in pilot trials as a treatment for Alzheimer’s where the drug led to improved memory and a reduced rate of progression of Alzheimer’s disease in subject mice. If proven successful in humans, nilvadipine will represent a big breakthrough in the field, as no new drugs have been approved for Alzheimer’s since 2002.

In an interview with Irish Medical News, Lawlor argued that Alzheimer’s disease “is one of the most significant health and social care problems that’s facing us with an ageing society and changing demographics; so it’s not just about the cost burden but also the impact on the person and on [caregivers] and society.”

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

Highlights

News
Articles and stories from Irish America.....
MORE

Hibernia
News from Ireland and happenings in Irish America.....
MORE

Those We Lost
Remembering some of the great Irish Americans who have passed.....
MORE

Slainte!
Discover Irish ancestry, predilections, and recipes.....
MORE

Photo Album
Irish America readers share the stories of their ancestors....
MORE

More Articles

  • Niall O'Dowd with Loretta Brennan Glucksman (center), co-chair of the Glucksman Ireland House at NYU, and Niall's wife Debbie McGoldrick, the Editor of the Irish Voice at the Friendly Sons of St. Patrick dinner on March 16. Photo courtesy John Sanderson/AnnieWatt.comHow the Irish Famine Changed American History
    Niall O'Dowd, Irish America's publisher, was the guest of honor at the Friendly Sons of St. Patrick...
  • <b>Moores Creek Bridge: A small battle with huge implications</b>Moores Creek Bridge: A small battle with huge implications
    Small bands of Patriots and Loyalists who fought with fierce devotion were formed during the early ...
  • <b>Mick Moloney Remembered at Irish Arts Center</b>Mick Moloney Remembered at Irish Arts Center
    Mick Moloney, a legend in the history of Irish music, who passed away suddenly on July 30, 2022, wil...
  • <b>Meet the man who will lead the 2023 NYC St. Patrick’s Day Parade</b>Meet the man who will lead the 2023 NYC St. Patrick’s Day Parade
    Kevin J. Conway, the grand marshal of the 2023 New York City St. Patrick’s Day parade is the gre...

Footer

Follow Us

  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
  • YouTube

Subscribe

  • Subscribe
  • Give a Gift
  • Newsletter
  • Customer Service

Additional

  • Advertise
  • Contact
  • Terms of Use & Privacy Policy

Copyright © 2023 · IrishAmerica Child Theme on Genesis Framework · WordPress · Log in